Schedule 13D ownership disclosure
Arcturus Therapeutics Ltd.
Security class unavailable · CUSIP: M1492T105
Event date: 2018-02-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 13.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-18-000177
- Form type
- SC 13D
- Filer
- Arcturus Therapeutics Ltd.
- CIK
- CIK 1566049
- Filed
- Feb 13, 2018
- Reporting period
- Feb 12, 2018
- Description
- Schedule 13D beneficial ownership